For the three months ended June 30, 2013, the hospital operator reported about $2.4 billion in net operating revenues, a 6.9 percent increase from around $2.3 billion in the same quarter of 2012. However, the company also experienced $171 million in losses from early extinguishment of debt in the second quarter of 2013. Its inpatient admissions also declined by 3.5 percent in the quarter, offsetting a 2.5 percent increase in outpatient admissions.
Tenet’s adjusted EBITDA was $336 million in the second quarter of 2013, a 16.7 percent increase from $288 million in the second quarter of 2012.
For the six months ended June 30, 2013, Tenet reported about $4.8 billion in net revenues, a 5.3 percent increase from nearly $4.6 billion in the first six months of 2012. However, it saw $138 million in losses in the first six months of 2013 as well, compared to $52 million in net income for the six months ended June 30, 2012.
In June, Tenet agreed to buy Nashville, Tenn.-based Vanguard Health System in a total transaction valued at $4.3 billion. The deal is expected to close by the end of 2013, and Tenet expects anywhere from $100 million to $200 million annually in savings through the revenue cycle, supply chain and other efficiencies of scale.
More Articles on Tenet Healthcare:
Tenet to Pay Above-Market Rates for Vanguard’s Chicago Hospitals
Tenet, HMA Accused of Kickback Scheme
10 Must-Read Stories on Consolidation in Healthcare
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
